Show simple item record

dc.contributor.authorKong, V
dc.contributor.authorHansen, VN
dc.contributor.authorHafeez, S
dc.date.accessioned2021-08-12T10:04:41Z
dc.date.available2021-08-12T10:04:41Z
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2021, 33 (6), pp. 350 - 368
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4746
dc.identifier.eissn1433-2981
dc.identifier.eissn1433-2981en_US
dc.identifier.doi10.1016/j.clon.2021.03.023
dc.identifier.doi10.1016/j.clon.2021.03.023en_US
dc.description.abstractTechnological advancement has facilitated patient-specific radiotherapy in bladder cancer. This has been made possible by developments in image-guided radiotherapy (IGRT). Particularly transformative has been the integration of volumetric imaging into the workflow. The ability to visualise the bladder target using cone beam computed tomography and magnetic resonance imaging initially assisted with determining the magnitude of inter- and intra-fraction target change. It has led to greater confidence in ascertaining true anatomy at each fraction. The increased certainty of dose delivered to the bladder has permitted the safe reduction of planning target volume margins. IGRT has therefore improved target coverage with a reduction in integral dose to the surrounding tissue. Use of IGRT to feed back into plan and dose delivery optimisation according to the anatomy of the day has enabled adaptive radiotherapy bladder solutions. Here we undertake a review of the stepwise developments underpinning IGRT and adaptive radiotherapy strategies for external beam bladder cancer radiotherapy. We present the evidence in accordance with the framework for systematic clinical evaluation of technical innovations in radiation oncology (R-IDEAL).
dc.formatPrint
dc.format.extent350 - 368
dc.languageeng
dc.language.isoeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleImage-guided Adaptive Radiotherapy for Bladder Cancer.
dc.typeJournal Article
dcterms.dateAccepted2021-03-30
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.clon.2021.03.023
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.publication-statusPublished
pubs.volume33en_US
pubs.embargo.termsNot known
icr.researchteamClinical Academic Radiotherapy (Huddart)
icr.researchteamClinical Academic Radiotherapy (Huddart)en_US
dc.contributor.icrauthorHafeez, Shaistaen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/